 | Form 4 Filings | Insider Buys | Significant Buys | Penny Stocks Insider Buying | Insider Sales |
| Insider Buy Sell Ratios | Stock Options | Insider Trading Stock Screener | Insider Trading Graph View | Insider Watch |
Insider Trading - TUFTS LINDA
| | "Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise" - Peter Lynch What is insider trading>> |
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2018-10-22 Purchase | 2018-10-24 4:20 pm | PhaseBio Pharmaceuticals Inc | PHAS | TUFTS LINDA Director | 20,000 | $5 | $100,000 | 281,096 (Indirect) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2018-10-22 Conversion | 2018-10-24 4:20 pm | N/A N/A | PhaseBio Pharmaceuticals Inc | PHAS | TUFTS LINDA Director | 577,486 | $0 | 281,096 (Indirect) | View |
| 2018-10-22 Conversion | 2018-10-24 4:20 pm | N/A N/A | PhaseBio Pharmaceuticals Inc | PHAS | TUFTS LINDA Director | 58,152 | $0 | 281,096 (Indirect) | View |
| 2018-10-22 Conversion | 2018-10-24 4:20 pm | N/A N/A | PhaseBio Pharmaceuticals Inc | PHAS | TUFTS LINDA Director | 275,055 | $0 | 281,096 (Indirect) | View |
| 2018-10-22 Exercise | 2018-10-24 4:20 pm | N/A N/A | PhaseBio Pharmaceuticals Inc | PHAS | TUFTS LINDA Director | 7,053 | $0.12 | 281,096 (Indirect) | View |
| 2018-10-22 Exercise | 2018-10-24 4:20 pm | N/A N/A | PhaseBio Pharmaceuticals Inc | PHAS | TUFTS LINDA Director | 7,053 | $0.12 | 281,096 (Indirect) | View |
| 2018-10-22 Sale | 2018-10-24 4:20 pm | N/A N/A | PhaseBio Pharmaceuticals Inc | PHAS | TUFTS LINDA Director | 170 | $5 | 281,096 (Indirect) | View |
| 2018-10-22 Exercise | 2018-10-24 4:20 pm | N/A N/A | PhaseBio Pharmaceuticals Inc | PHAS | TUFTS LINDA Director | 710 | $0.12 | 281,096 (Indirect) | View |
| 2018-10-22 Exercise | 2018-10-24 4:20 pm | N/A N/A | PhaseBio Pharmaceuticals Inc | PHAS | TUFTS LINDA Director | 710 | $0.12 | 281,096 (Indirect) | View |
| 2018-10-22 Sale | 2018-10-24 4:20 pm | N/A N/A | PhaseBio Pharmaceuticals Inc | PHAS | TUFTS LINDA Director | 18 | $5 | 281,096 (Indirect) | View |
| 2018-10-22 Exercise | 2018-10-24 4:20 pm | N/A N/A | PhaseBio Pharmaceuticals Inc | PHAS | TUFTS LINDA Director | 3,359 | $0.12 | 281,096 (Indirect) | View |
| 2018-10-22 Exercise | 2018-10-24 4:20 pm | N/A N/A | PhaseBio Pharmaceuticals Inc | PHAS | TUFTS LINDA Director | 3,359 | $0.12 | 281,096 (Indirect) | View |
| 2018-10-22 Sale | 2018-10-24 4:20 pm | N/A N/A | PhaseBio Pharmaceuticals Inc | PHAS | TUFTS LINDA Director | 81 | $5 | 281,096 (Indirect) | View |
| 2018-10-22 Exercise | 2018-10-24 4:20 pm | N/A N/A | PhaseBio Pharmaceuticals Inc | PHAS | TUFTS LINDA Director | 9,847 | $0.12 | 281,096 (Indirect) | View |
| 2018-10-22 Exercise | 2018-10-24 4:20 pm | N/A N/A | PhaseBio Pharmaceuticals Inc | PHAS | TUFTS LINDA Director | 9,847 | $0.12 | 281,096 (Indirect) | View |
| 2018-10-22 Sale | 2018-10-24 4:20 pm | N/A N/A | PhaseBio Pharmaceuticals Inc | PHAS | TUFTS LINDA Director | 237 | $5 | 281,096 (Indirect) | View |
| 2018-10-22 Exercise | 2018-10-24 4:20 pm | N/A N/A | PhaseBio Pharmaceuticals Inc | PHAS | TUFTS LINDA Director | 991 | $0.12 | 281,096 (Indirect) | View |
| 2018-10-22 Exercise | 2018-10-24 4:20 pm | N/A N/A | PhaseBio Pharmaceuticals Inc | PHAS | TUFTS LINDA Director | 991 | $0.12 | 281,096 (Indirect) | View |
| 2018-10-22 Sale | 2018-10-24 4:20 pm | N/A N/A | PhaseBio Pharmaceuticals Inc | PHAS | TUFTS LINDA Director | 24 | $5 | 281,096 (Indirect) | View |
| 2018-10-22 Exercise | 2018-10-24 4:20 pm | N/A N/A | PhaseBio Pharmaceuticals Inc | PHAS | TUFTS LINDA Director | 4,690 | $0.12 | 281,096 (Indirect) | View |
| 2018-10-22 Exercise | 2018-10-24 4:20 pm | N/A N/A | PhaseBio Pharmaceuticals Inc | PHAS | TUFTS LINDA Director | 4,690 | $0.12 | 281,096 (Indirect) | View |
| 2018-10-22 Sale | 2018-10-24 4:20 pm | N/A N/A | PhaseBio Pharmaceuticals Inc | PHAS | TUFTS LINDA Director | 113 | $5 | 281,096 (Indirect) | View |
| 2018-10-22 Conversion | 2018-10-24 4:20 pm | N/A N/A | PhaseBio Pharmaceuticals Inc | PHAS | TUFTS LINDA Director | 119,408 | $0 | 281,096 (Indirect) | View |
| 2018-10-22 Conversion | 2018-10-24 4:20 pm | N/A N/A | PhaseBio Pharmaceuticals Inc | PHAS | TUFTS LINDA Director | 12,025 | $0 | 281,096 (Indirect) | View |
| 2018-10-22 Conversion | 2018-10-24 4:20 pm | N/A N/A | PhaseBio Pharmaceuticals Inc | PHAS | TUFTS LINDA Director | 56,874 | $0 | 281,096 (Indirect) | View |
| 2018-10-22 Conversion | 2018-10-24 4:20 pm | N/A N/A | PhaseBio Pharmaceuticals Inc | PHAS | TUFTS LINDA Director | 347,250 | $0 | 281,096 (Indirect) | View |
| 2018-10-22 Conversion | 2018-10-24 4:20 pm | N/A N/A | PhaseBio Pharmaceuticals Inc | PHAS | TUFTS LINDA Director | 34,968 | $0 | 281,096 (Indirect) | View |
| 2018-10-22 Conversion | 2018-10-24 4:20 pm | N/A N/A | PhaseBio Pharmaceuticals Inc | PHAS | TUFTS LINDA Director | 165,395 | $0 | 281,096 (Indirect) | View |
| 2018-10-22 Conversion | 2018-10-24 4:20 pm | N/A N/A | PhaseBio Pharmaceuticals Inc | PHAS | TUFTS LINDA Director | 47,140 | $0 | 281,096 (Indirect) | View |
| 2018-10-22 Conversion | 2018-10-24 4:20 pm | N/A N/A | PhaseBio Pharmaceuticals Inc | PHAS | TUFTS LINDA Director | 4,746 | $0 | 281,096 (Indirect) | View |
| 2018-10-22 Conversion | 2018-10-24 4:20 pm | N/A N/A | PhaseBio Pharmaceuticals Inc | PHAS | TUFTS LINDA Director | 22,452 | $0 | 281,096 (Indirect) | View |
| 2018-10-22 Conversion | 2018-10-24 4:20 pm | N/A N/A | PhaseBio Pharmaceuticals Inc | PHAS | TUFTS LINDA Director | 63,688 | $0 | 281,096 (Indirect) | View |
| 2018-10-22 Conversion | 2018-10-24 4:20 pm | N/A N/A | PhaseBio Pharmaceuticals Inc | PHAS | TUFTS LINDA Director | 6,413 | $0 | 281,096 (Indirect) | View |
| 2018-10-22 Conversion | 2018-10-24 4:20 pm | N/A N/A | PhaseBio Pharmaceuticals Inc | PHAS | TUFTS LINDA Director | 30,334 | $0 | 281,096 (Indirect) | View |
| 2019-02-27 Option Award | 2019-03-01 5:23 pm | N/A 2029-02-27 | PhaseBio Pharmaceuticals Inc | PHAS | TUFTS LINDA Director | 36,000 | $3.15 | 36,000 (Direct) | View |